RecruitingPhase 1 / Phase 2NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor: Genmab
Doylestown, PA · Pittsburgh, PA · +35 more sites
Breast Cancer clinical trials in Pittsburgh, PA
25 recruiting breast cancer studies with a site in Pittsburgh, PA.
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Pittsburgh, PA · +15 more sites
RecruitingPhase 3NCT06790693
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Sponsor: Hoffmann-La Roche
Pittsburgh, PA · +61 more sites
RecruitingNot applicableNCT07059884
Distance-Based Exercise to Preserve Function and Prevent Disability
Sponsor: Alliance for Clinical Trials in Oncology
Butler, PA · Indiana, PA · New Castle, PA · +20 more sites
RecruitingNot applicableNCT07698314
A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Pittsburgh, PA
RecruitingPhase 1NCT05877599
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Sponsor: AstraZeneca
Pittsburgh, PA · +19 more sites
RecruitingNot applicableNCT07214532
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sponsor: Natera, Inc.
Pittsburgh, PA · +48 more sites
RecruitingPhase 2NCT06923527
Circulating Tumor DNA
Sponsor: Yale University
Pittsburgh, PA · +6 more sites
RecruitingPhase 1NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Sponsor: Aktis Oncology, Inc.
Pittsburgh, PA · +13 more sites
RecruitingPhase not listedNCT07262138
Active Surveillance in Older Women With ER+ Breast Cancer
Sponsor: University of Pittsburgh
Pittsburgh, PA
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Allentown, PA · Bethlehem, PA · +1223 more sites
RecruitingPhase 2NCT05919108
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Sponsor: Vanderbilt-Ingram Cancer Center
Pittsburgh, PA · +4 more sites
RecruitingNot applicableNCT06105749
Biennial CEM in Women With a Personal History of Breast Cancer
Sponsor: Wendie Berg
Bethel Park, PA · Cranberry Township, PA · Monroeville, PA · +3 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Allentown, PA · Bethlehem, PA · Chambersburg, PA · +825 more sites
RecruitingPhase 3NCT06748222
E-Mindfulness Approaches for Living After Breast Cancer
Sponsor: NRG Oncology
Carlisle, PA · Chambersburg, PA · Danville, PA · +378 more sites
RecruitingPhase not listedNCT06551116
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Philadelphia, PA · Pittsburgh, PA · +34 more sites
RecruitingPhase 3NCT05696626
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Sponsor: LeonaBio
Pittsburgh, PA · +35 more sites
RecruitingPhase 1NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Sponsor: Orano Med Theranostics, SAS
Pittsburgh, PA · +7 more sites
RecruitingPhase not listedNCT07332975
ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
Sponsor: University of Pittsburgh
Pittsburgh, PA
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Allentown, PA · Bethlehem, PA · Broomall, PA · +809 more sites
RecruitingPhase not listedNCT03448926
The PREDICT Registry:
Sponsor: PreludeDx
Easton, PA · Philadelphia, PA · Pittsburgh, PA · +27 more sites
RecruitingPhase not listedNCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Sponsor: UMC Utrecht
Pittsburgh, PA · +2 more sites
RecruitingPhase 2NCT03804944
Converting HR+ Breast Cancer Into an Individualized Vaccine
Sponsor: Weill Medical College of Cornell University
Pittsburgh, PA · +7 more sites
RecruitingPhase 3NCT05929768
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Allentown, PA · Bethlehem, PA · Bryn Mawr, PA · +952 more sites
RecruitingPhase 1 / Phase 2NCT06249048
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Sponsor: Strand Therapeutics Inc.
Pittsburgh, PA · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.